Jacobs Levy Equity Management’s Sanara MedTech SMTI Stock Holding History

Jacobs Levy Equity Management’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$746K	Buy	+31,644	New	+$654K	﹤0.01%	761

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jacobs Levy Equity Management's SMTI Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Sanara MedTech (SMTI) in Q2 2026: 31,644 shares worth $746K. The stake represents ﹤0.01% of the portfolio and ranks #761 among its holdings.

75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Jacobs Levy Equity Management held 31,644 shares of Sanara MedTech worth $746K as of Q2 2026.
Sanara MedTech was a new Jacobs Levy Equity Management position in Q2 2026.
Sanara MedTech made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #761 holding.
75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.